{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:49:35Z","timestamp":1781880575123,"version":"3.54.5"},"reference-count":152,"publisher":"Jaypee Brothers Medical Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.59556\/japi.74.1445","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:50:37Z","timestamp":1773222637000},"page":"e1-e16","source":"Crossref","is-referenced-by-count":1,"title":["iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity: Focus on Prevention and Treatment of Cardiometabolic Disease"],"prefix":"10.59556","volume":"74","author":[{"given":"Stefan D","family":"Anker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Kindel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew JS","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dike","family":"Ojji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Puente","family":"Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Zieroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaaf","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shariq","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Appannah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Bennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brandao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomira","family":"Fabryova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Lin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday M","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel W","family":"Le Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto J","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Sabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh","family":"Tiwaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol E","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang","family":"Wei Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Stuardo","family":"Wyss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter P","family":"Abhayaratna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael Al","family":"Mahmeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Argir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Belardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Campuzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andr\u00e9","family":"Cornier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemencia","family":"de Rueda Panadero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastase","family":"Dzudie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ty J","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahzeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Lopatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechukwu S","family":"Ogah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Oomman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio S Peralta","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Redfern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe MC","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"key":"key20260311095033_B1","doi-asserted-by":"crossref","first-page":"157\u2013","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.","volume":"363:","year":"2004;","journal-title":"Lancet"},{"key":"key20260311095033_B2","doi-asserted-by":"crossref","first-page":"e162\u2013","DOI":"10.1016\/S2468-2667(18)30021-5","article-title":"Prevalence trends tell us what did not precipitate the US obesity epidemic.","volume":"3:","author":"Rodgers","year":"2018;","journal-title":"Lancet Public Health"},{"key":"key20260311095033_B3","doi-asserted-by":"crossref","first-page":"4253.","DOI":"10.3390\/nu14204253","article-title":"The origins of the obesity epidemic in the USA-lessons for today.","volume":"14:","author":"Temple","year":"2022;","journal-title":"Nutrients"},{"key":"key20260311095033_B4","doi-asserted-by":"crossref","first-page":"221\u2013","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity.","volume":"13:","author":"Rubino","year":"2025;","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20260311095033_B5","doi-asserted-by":"crossref","first-page":"243\u2013","DOI":"10.1007\/s13167-021-00251-4","article-title":"Caution, \u201dnormal\u201d BMI: health risks associated with potentially masked individual underweight-EPMA position paper 2021.","volume":"12:","author":"Golubnitschaja","year":"2021;","journal-title":"EPMA J"},{"key":"key20260311095033_B6","doi-asserted-by":"crossref","first-page":"813\u2013","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.","volume":"405:","author":"Ng","year":"2025;","journal-title":"Lancet"},{"key":"key20260311095033_B7","first-page":"354\u2013","article-title":"Direct medical costs of obesity in the United States and the most populous states.","volume":"27:","author":"Cawley","year":"2021;","journal-title":"J Manag Care Spec Pharm"},{"key":"key20260311095033_B8","doi-asserted-by":"crossref","first-page":"50\u2013","DOI":"10.1111\/j.1467-789X.2009.00708.x","article-title":"Direct medical cost of overweight and obesity in the USA: a quantitative systematic review.","volume":"12:","author":"Tsai","year":"2011;","journal-title":"Obes Rev"},{"key":"key20260311095033_B9","doi-asserted-by":"crossref","first-page":"e009773.","DOI":"10.1136\/bmjgh-2022-009773","article-title":"Economic impacts of overweight and obesity: current and future estimates for 161 countries.","volume":"7:","author":"Okunogbe","year":"2022;","journal-title":"BMJ Global Health"},{"key":"key20260311095033_B10","first-page":"51s\u2013","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report.","volume":"6:","year":"1998;","journal-title":"National Institutes of Health Obes Res"},{"key":"key20260311095033_B11","doi-asserted-by":"crossref","first-page":"S1\u2013","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity.","volume":"22:","author":"Garvey","year":"2016;","journal-title":"Endocr Pract"},{"key":"key20260311095033_B12","doi-asserted-by":"crossref","first-page":"4043\u2013","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC).","volume":"44:","author":"Marx","year":"2023;","journal-title":"Eur Heart J"},{"key":"key20260311095033_B13","doi-asserted-by":"crossref","first-page":"1198\u2013","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity.","volume":"163:","author":"Grunvald","year":"2022;","journal-title":"Gastroenterology"},{"key":"key20260311095033_B14","first-page":"450\u2013","article-title":"Guidelines for medical nutrition treatment of overweight\/obesity in China (2021).","volume":"31:","author":"Nutrition and Metabolic Management Branch of China International Exchange and Promotive Association for Medical and Health Care, Clinical Nutrition Branch of Chinese Nutrition Society, Chinese Diabetes Society,","year":"2022;","journal-title":"Asia Pac J Clin Nutr"},{"key":"key20260311095033_B15","doi-asserted-by":"crossref","first-page":"S158\u2013","DOI":"10.2337\/dc24-S009","article-title":"American Diabetes Association Professional Practice Committee. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2024.","volume":"47:","year":"2024;","journal-title":"Diabetes Care"},{"key":"key20260311095033_B16","doi-asserted-by":"crossref","first-page":"3227\u2013","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice.","volume":"42:","author":"Visseren","year":"2021;","journal-title":"Eur Heart J"},{"key":"key20260311095033_B17","first-page":"e596\u2013","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines.","volume":"140:","author":"Arnett","year":"2019;","journal-title":"Circulation"},{"key":"key20260311095033_B18","doi-asserted-by":"crossref","first-page":"E1460\u2013","DOI":"10.1503\/cmaj.220138","article-title":"Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update.","volume":"194:","author":"Jain","year":"2022;","journal-title":"CMAJ"},{"key":"key20260311095033_B19","doi-asserted-by":"crossref","first-page":"482\u2013","DOI":"10.5694\/mja2.52280","article-title":"2023 Australian guideline for assessing and managing cardiovascular disease risk.","volume":"220:","author":"Nelson","year":"2024;","journal-title":"Med J Aust"},{"key":"key20260311095033_B20","doi-asserted-by":"crossref","first-page":"S117\u2013","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease.","volume":"105:","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.","year":"2024;","journal-title":"Kidney Int"},{"key":"key20260311095033_B21","first-page":"e13\u2013","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines.","volume":"71:","author":"Whelton","year":"2018;","journal-title":"Hypertension"},{"key":"key20260311095033_B22","doi-asserted-by":"crossref","first-page":"1874\u2013","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).","volume":"41:","author":"Mancia","year":"2023;","journal-title":"J Hypertens"},{"key":"key20260311095033_B23","doi-asserted-by":"crossref","first-page":"528\u2013","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD).","volume":"28:","author":"Cusi","year":"2022;","journal-title":"Endocr Pract"},{"key":"key20260311095033_B24","doi-asserted-by":"crossref","first-page":"108101.","DOI":"10.1016\/j.jdiacomp.2021.108101","article-title":"DCRM: multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.","volume":"36:","author":"Handelsman","year":"2022;","journal-title":"J Diabetes Complications"},{"key":"key20260311095033_B25","doi-asserted-by":"crossref","first-page":"3599\u2013","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"42:","author":"McDonagh","year":"2021;","journal-title":"Eur Heart J"},{"key":"key20260311095033_B26","doi-asserted-by":"crossref","first-page":"1123\u2013","DOI":"10.1016\/j.hlc.2018.06.1042","article-title":"National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018.","volume":"27:","author":"Atherton","year":"2018;","journal-title":"Heart Lung Circ"},{"key":"key20260311095033_B27","doi-asserted-by":"crossref","first-page":"E875.","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline.","volume":"192:","author":"Wharton","year":"2020;","journal-title":"CMAJ"},{"key":"key20260311095033_B28","doi-asserted-by":"crossref","first-page":"536\u2013","DOI":"10.1016\/j.jacc.2025.05.024","article-title":"2025 concise clinical guidance: an ACC expert consensus statement on medical weight management for optimization of cardiovascular health: a report of the American College of Cardiology Solution Set Oversight Committee.","volume":"86:","author":"Gilbert","year":"2025;","journal-title":"J Am Coll Cardiol"},{"key":"key20260311095033_B29","doi-asserted-by":"crossref","first-page":"e062158.","DOI":"10.1136\/bmjopen-2022-062158","article-title":"Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews.","volume":"13:","author":"Wang","year":"2023;","journal-title":"BMJ Open"},{"key":"key20260311095033_B30","doi-asserted-by":"crossref","first-page":"590\u2013","DOI":"10.5604\/12321966.1120608","article-title":"Obesity and poverty paradox in developed countries.","volume":"21:","author":"\u017bukiewicz-Sobczak","year":"2014;","journal-title":"Ann Agric Environ Med"},{"key":"key20260311095033_B31","doi-asserted-by":"crossref","first-page":"1636\u2013","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association.","volume":"148:","author":"Ndumele","year":"2023;","journal-title":"Circulation"},{"key":"key20260311095033_B32","article-title":"FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight.","author":"US Food and Drug Administration.","year":"(2024)."},{"key":"key20260311095033_B33","doi-asserted-by":"crossref","first-page":"419\u2013","DOI":"10.1016\/S2213-8587(21)00088-7","article-title":"Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study.","volume":"9:","author":"Caleyachetty","year":"2021;","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20260311095033_B34","doi-asserted-by":"crossref","first-page":"485\u2013","DOI":"10.1038\/s41591-020-0803-x","article-title":"Joint international consensus statement for ending stigma of obesity.","volume":"26:","author":"Rubino","year":"2020;","journal-title":"Nat Med"},{"key":"key20260311095033_B35","doi-asserted-by":"crossref","first-page":"70\u2013","DOI":"10.1016\/j.appet.2016.02.032","article-title":"The relationship between weight stigma and eating behavior is explained by weight bias internalization and psychological distress.","volume":"102:","author":"O'Brien","year":"2016;","journal-title":"Appetite"},{"key":"key20260311095033_B36","doi-asserted-by":"crossref","first-page":"3\u2013","DOI":"10.1016\/j.appet.2016.01.034","article-title":"Weight stigma and eating behavior: a review of the literature.","volume":"102:","author":"Vartanian","year":"2016;","journal-title":"Appetite"},{"key":"key20260311095033_B37","first-page":"27\u2013","article-title":"Clinical review: modified 5 As: minimal intervention for obesity counseling in primary care.","volume":"59:","author":"Vallis","year":"2013;","journal-title":"Can Fam Physician"},{"key":"key20260311095033_B38","doi-asserted-by":"crossref","first-page":"959\u2013","DOI":"10.1038\/ijo.2008.11","article-title":"Accuracy of body mass index in diagnosing obesity in the adult general population.","volume":"32:","author":"Romero-Corral","year":"2008;","journal-title":"Int J Obes (London)"},{"key":"key20260311095033_B39","doi-asserted-by":"crossref","first-page":"23\u2013","DOI":"10.1093\/ajcn\/60.1.23","article-title":"Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements.","volume":"60:","author":"Wang","year":"1994;","journal-title":"Am J Clin Nutr"},{"key":"key20260311095033_B40","article-title":"Waist circumference and waist\u2013hip ratio: report of a WHO expert consultation.","author":"World Health Organization.","year":"(2008)."},{"key":"key20260311095033_B41","doi-asserted-by":"crossref","first-page":"1294\u2013","DOI":"10.1038\/s41390-022-02223-4","article-title":"Diagnosis accuracy of waist-to-height ratio to predict cardiometabolic risk in children with obesity.","volume":"93:","author":"Mu\u00f1oz-Hernando","year":"2023;","journal-title":"Pediatr Res"},{"key":"key20260311095033_B42","doi-asserted-by":"crossref","first-page":"525\u2013","DOI":"10.1089\/met.2008.0102","article-title":"Index of central obesity is better than waist circumference in defining metabolic syndrome.","volume":"7:","author":"Parikh","year":"2009;","journal-title":"Metab Syndr Relat Disord"},{"key":"key20260311095033_B43","doi-asserted-by":"crossref","first-page":"141\u2013","DOI":"10.1046\/j.1467-789X.2002.00065.x","article-title":"Asians are different from Caucasians and from each other in their body mass index\/body fat per cent relationship.","volume":"3:","author":"Deurenberg","year":"2002;","journal-title":"Obes Rev"},{"key":"key20260311095033_B44","doi-asserted-by":"crossref","first-page":"574\u2013","DOI":"10.2337\/dc12-0722","article-title":"Elevated rates of diabetes in Pacific Islanders and Asian subgroups: the Diabetes Study of Northern California (DISTANCE).","volume":"36:","author":"Karter","year":"2013;","journal-title":"Diabetes Care"},{"key":"key20260311095033_B45","doi-asserted-by":"crossref","first-page":"195.","DOI":"10.1186\/s12902-022-01111-6","article-title":"Body fat assessment in youth with overweight or obesity by an automated bioelectrical impedance analysis device, in comparison with the dual-energy x-ray absorptiometry: a cross sectional study.","volume":"22:","author":"Samouda","year":"2022;","journal-title":"BMC Endocr Disord"},{"key":"key20260311095033_B46","doi-asserted-by":"crossref","first-page":"449S\u2013","DOI":"10.1093\/ajcn\/64.3.449S","article-title":"Limitations of the bioelectrical impedance method for the assessment of body fat in severe obesity.","volume":"64:","author":"Deurenberg","year":"1996;","journal-title":"Am J Clin Nutr"},{"key":"key20260311095033_B47","doi-asserted-by":"crossref","first-page":"1232\u2013","DOI":"10.1038\/oby.2005.146","article-title":"Air displacement plethysmography: validation in overweight and obese subjects.","volume":"13:","author":"Ginde","year":"2005;","journal-title":"Obes Res"},{"key":"key20260311095033_B48","first-page":"19\u2013","article-title":"Obesity: lifestyle modification and behavior interventions.","volume":"492:","author":"Wilson","year":"2020;","journal-title":"FP Essent"},{"key":"key20260311095033_B49","doi-asserted-by":"crossref","first-page":"S102\u2013","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults.","volume":"129:","author":"Jensen","year":"2014;","journal-title":"Circulation"},{"key":"key20260311095033_B50","doi-asserted-by":"crossref","first-page":"1\u2013","DOI":"10.1089\/met.2010.0031","article-title":"Mediterranean diet and weight loss: meta-analysis of randomized controlled trials.","volume":"9:","author":"Esposito","year":"2011;","journal-title":"Metab Syndr Relat Disord"},{"key":"key20260311095033_B51","doi-asserted-by":"crossref","first-page":"874\u2013","DOI":"10.1017\/S0007114520001798","article-title":"Exploring the relationship between the Mediterranean diet and weight loss maintenance: the MedWeight study.","volume":"124:","author":"Poulimeneas","year":"2020;","journal-title":"Br J Nutr"},{"key":"key20260311095033_B52","doi-asserted-by":"crossref","first-page":"442\u2013","DOI":"10.1111\/obr.12391","article-title":"The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials.","volume":"17:","author":"Soltani","year":"2016;","journal-title":"Obes Rev"},{"key":"key20260311095033_B53","first-page":"e71623.","article-title":"The role of intermittent fasting on metabolic syndrome: a systematic review and meta-analysis.","volume":"16:","author":"Almabruk","year":"2024;","journal-title":"Cureus"},{"key":"key20260311095033_B54","doi-asserted-by":"crossref","first-page":"780\u2013","DOI":"10.1038\/ejcn.2012.37","article-title":"Effects of higher- versus lower-protein diets on health outcomes: a systematic review and meta-analysis.","volume":"66:","author":"Santesso","year":"2012;","journal-title":"Eur J Clin Nutr"},{"key":"key20260311095033_B55","doi-asserted-by":"crossref","first-page":"1545\u2013","DOI":"10.1038\/sj.ijo.0801453","article-title":"The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies.","volume":"24:","author":"Astrup","year":"2000;","journal-title":"Int J Obes Relat Metab Disord"},{"key":"key20260311095033_B56","doi-asserted-by":"crossref","first-page":"229\u2013","DOI":"10.1056\/NEJMoa0708681","article-title":"Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.","volume":"359:","author":"Shai","year":"2008;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B57","doi-asserted-by":"crossref","first-page":"e34.","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts.","volume":"378:","author":"Estruch","year":"2018;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B58","doi-asserted-by":"crossref","first-page":"e55030.","DOI":"10.1371\/journal.pone.0055030","article-title":"Low-carbohydrate diets and all-cause mortality: a systematic review and meta-analysis of observational studies.","volume":"8:","author":"Noto","year":"2013;","journal-title":"PLoS One"},{"key":"key20260311095033_B59","doi-asserted-by":"crossref","first-page":"192.","DOI":"10.1186\/s12916-023-02869-9","article-title":"The effect of dietary carbohydrate and calorie restriction on weight and metabolic health in overweight\/obese individuals: a multicenter randomized controlled trial.","volume":"21:","author":"Sun","year":"2023;","journal-title":"BMC Med"},{"key":"key20260311095033_B60","doi-asserted-by":"crossref","first-page":"1281\u2013","DOI":"10.3945\/ajcn.112.044321","article-title":"Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials.","volume":"96:","author":"Wycherley","year":"2012;","journal-title":"Am J Clin Nutr"},{"key":"key20260311095033_B61","doi-asserted-by":"crossref","first-page":"e13256.","DOI":"10.1111\/obr.13256","article-title":"Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: an overview of 12 systematic reviews and 149 studies.","volume":"22:","author":"Bellicha","year":"2021;","journal-title":"Obes Rev"},{"key":"key20260311095033_B62","doi-asserted-by":"crossref","first-page":"206\u2013","DOI":"10.1249\/MSS.0000000000001074","article-title":"Effects of weight loss on lean mass, strength, bone, and aerobic capacity.","volume":"49:","author":"Weiss","year":"2017;","journal-title":"Med Sci Sports Exerc"},{"key":"key20260311095033_B63","doi-asserted-by":"crossref","first-page":"1786\u2013","DOI":"10.1038\/sj.ijo.0803683","article-title":"A dose\u2013response relation between aerobic exercise and visceral fat reduction: systematic review of clinical trials.","volume":"31:","author":"Ohkawara","year":"2007;","journal-title":"Int J Obes (Lond)"},{"key":"key20260311095033_B64","doi-asserted-by":"crossref","first-page":"206\u2013","DOI":"10.1016\/j.pcad.2018.07.014","article-title":"The effects of exercise and physical activity on weight loss and maintenance. Progress in cardiovascular diseases.","volume":"61:","author":"Swift","year":"2018;","journal-title":"Prog Cardiovasc Dis"},{"key":"key20260311095033_B65","doi-asserted-by":"crossref","first-page":"1831\u2013","DOI":"10.1152\/japplphysiol.01370.2011","article-title":"Effects of aerobic and\/or resistance training on body mass and fat mass in overweight or obese adults.","volume":"113:","author":"Willis","year":"2012;","journal-title":"J Appl Physiol (1985)"},{"key":"key20260311095033_B66","doi-asserted-by":"crossref","first-page":"153\u2013","DOI":"10.1038\/oby.2007.6","article-title":"Physical activity patterns in the National Weight Control Registry.","volume":"16:","author":"Catenacci","year":"2008;","journal-title":"Obesity (Silver Spring)"},{"key":"key20260311095033_B67","doi-asserted-by":"crossref","first-page":"1550\u2013","DOI":"10.1001\/archinte.168.14.1550","article-title":"Effect of exercise on 24-month weight loss maintenance in overweight women.","volume":"168:","author":"Jakicic","year":"2008;","journal-title":"Arch Intern Med"},{"key":"key20260311095033_B68","doi-asserted-by":"crossref","first-page":"311\u2013","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes.","volume":"375:","author":"Marso","year":"2016;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B69","doi-asserted-by":"crossref","first-page":"11\u2013","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management.","volume":"373:","author":"Pi-Sunyer","year":"2015;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B70","doi-asserted-by":"crossref","first-page":"1443\u2013","DOI":"10.1038\/ijo.2013.120","article-title":"Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study.","volume":"37:","author":"Wadden","year":"2013;","journal-title":"Int J Obes (Lond)"},{"key":"key20260311095033_B71","doi-asserted-by":"crossref","first-page":"687\u2013","DOI":"10.1001\/jama.2015.9676","article-title":"Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial.","volume":"314:","author":"Davies","year":"2015;","journal-title":"JAMA"},{"key":"key20260311095033_B72","doi-asserted-by":"crossref","first-page":"1310\u2013","DOI":"10.1038\/ijo.2016.52","article-title":"Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE sleep apnea randomized clinical trial.","volume":"40:","author":"Blackman","year":"2016;","journal-title":"Int J Obes (Lond)"},{"key":"key20260311095033_B73","doi-asserted-by":"crossref","first-page":"2424\u2013","DOI":"10.1001\/jama.2016.7602","article-title":"Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis.","volume":"315:","author":"Khera","year":"2016;","journal-title":"JAMA"},{"key":"key20260311095033_B74","doi-asserted-by":"crossref","first-page":"1399\u2013","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.","volume":"389:","author":"Le Roux","year":"2017;","journal-title":"Lancet"},{"key":"key20260311095033_B75","doi-asserted-by":"crossref","first-page":"202\u2013","DOI":"10.2337\/ds16-0026","article-title":"Glucagon-like peptide 1 receptor agonists for type 2 diabetes.","volume":"30:","author":"Hinnen","year":"2017;","journal-title":"Diabetes Spectr"},{"key":"key20260311095033_B76","doi-asserted-by":"crossref","first-page":"159\u2013","DOI":"10.1016\/j.tcm.2021.12.008","article-title":"Semaglutide for the treatment of obesity.","volume":"33:","author":"Chao","year":"2023;","journal-title":"Trends Cardiovasc Med"},{"key":"key20260311095033_B77","doi-asserted-by":"crossref","first-page":"989\u2013","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity.","volume":"384:","author":"Wilding","year":"2021;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B78","doi-asserted-by":"crossref","first-page":"971\u2013","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.","volume":"397:","author":"Davies","year":"2021;","journal-title":"Lancet"},{"key":"key20260311095033_B79","doi-asserted-by":"crossref","first-page":"1403\u2013","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial.","volume":"325:","author":"Wadden","year":"2021;","journal-title":"JAMA"},{"key":"key20260311095033_B80","doi-asserted-by":"crossref","first-page":"1414\u2013","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial.","volume":"325:","author":"Rubino","year":"2021;","journal-title":"JAMA"},{"key":"key20260311095033_B81","doi-asserted-by":"crossref","first-page":"2083\u2013","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial.","volume":"28:","author":"Garvey","year":"2022;","journal-title":"Nat Med"},{"key":"key20260311095033_B82","doi-asserted-by":"crossref","first-page":"138\u2013","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial.","volume":"327:","author":"Rubino","year":"2022;","journal-title":"JAMA"},{"key":"key20260311095033_B83","doi-asserted-by":"crossref","first-page":"1573\u2013","DOI":"10.1056\/NEJMoa2403664","article-title":"Once-weekly semaglutide in persons with obesity and knee osteoarthritis.","volume":"391:","author":"Bliddal","year":"2024;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B84","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00226-8","article-title":"Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial.","author":"Wharton","year":"2025.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20260311095033_B85","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00225-6","article-title":"Once-weekly semaglutide 7.2 mg in adults with obesity and type 2 diabetes (STEPUP T2D): a randomised, controlled, phase 3b trial.","author":"Lingvay","year":"2025.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20260311095033_B86","doi-asserted-by":"crossref","DOI":"10.2337\/dc25-1442","article-title":"Weight reduction with tirzepatide varied meaningfully by baseline HbA1c category in adults with overweight or obesity and type 2 diabetes in SURMOUNT-2.","author":"Sattar","year":"2025.","journal-title":"Diabetes Care"},{"key":"key20260311095033_B87","doi-asserted-by":"crossref","first-page":"613\u2013","DOI":"10.1016\/S0140-6736(23)01200-X","article-title":"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.","volume":"402:","author":"Garvey","year":"2023;","journal-title":"Lancet"},{"key":"key20260311095033_B88","doi-asserted-by":"crossref","first-page":"2221\u2013","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes.","volume":"389:","author":"Lincoff","year":"2023;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B89","doi-asserted-by":"crossref","first-page":"1069\u2013","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity.","volume":"389:","author":"Kosiborod","year":"2023;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B90","doi-asserted-by":"crossref","first-page":"1394\u2013","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes.","volume":"390:","author":"Kosiborod","year":"2024;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B91","doi-asserted-by":"crossref","first-page":"265\u2013","DOI":"10.1016\/j.jacc.2011.02.055","article-title":"Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction.","volume":"58:","author":"Haykowsky","year":"2011;","journal-title":"J Am Coll Cardiol"},{"key":"key20260311095033_B92","doi-asserted-by":"crossref","first-page":"1580\u2013","DOI":"10.1016\/S0140-6736(25)00509-4","article-title":"Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial.","volume":"405:","author":"Bonaca","year":"2025;","journal-title":"Lancet"},{"key":"key20260311095033_B93","doi-asserted-by":"crossref","first-page":"2089\u2013","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction\u2013associated steatohepatitis.","volume":"392:","author":"Sanyal","year":"2025;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B94","doi-asserted-by":"crossref","first-page":"143\u2013","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.","volume":"398:","author":"Rosenstock","year":"2021;","journal-title":"Lancet"},{"key":"key20260311095033_B95","doi-asserted-by":"crossref","first-page":"503\u2013","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes.","volume":"385:","author":"Fr\u00edas","year":"2021;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B96","doi-asserted-by":"crossref","first-page":"583\u2013","DOI":"10.1016\/S0140-6736(21)01443-4","article-title":"Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial.","volume":"398:","author":"Ludvik","year":"2021;","journal-title":"Lancet"},{"key":"key20260311095033_B97","doi-asserted-by":"crossref","first-page":"1811\u2013","DOI":"10.1016\/S0140-6736(21)02188-7","article-title":"Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.","volume":"398:","author":"Del Prato","year":"2021;","journal-title":"Lancet"},{"key":"key20260311095033_B98","doi-asserted-by":"crossref","first-page":"534\u2013","DOI":"10.1001\/jama.2022.0078","article-title":"Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: the SURPASS-5 randomized clinical trial.","volume":"327:","author":"Dahl","year":"2022;","journal-title":"JAMA"},{"key":"key20260311095033_B99","doi-asserted-by":"crossref","first-page":"205\u2013","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity.","volume":"387:","author":"Jastreboff","year":"2022;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B100","doi-asserted-by":"crossref","first-page":"958\u2013","DOI":"10.1056\/NEJMoa2410819","article-title":"Tirzepatide for obesity treatment and diabetes prevention.","volume":"392:","author":"Jastreboff","year":"2025;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B101","doi-asserted-by":"crossref","first-page":"2909\u2013","DOI":"10.1038\/s41591-023-02597-w","article-title":"Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.","volume":"29:","author":"Wadden","year":"2023;","journal-title":"Nat Med"},{"key":"key20260311095033_B102","doi-asserted-by":"crossref","first-page":"38\u2013","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial.","volume":"331:","author":"Aronne","year":"2024;","journal-title":"JAMA"},{"key":"key20260311095033_B103","doi-asserted-by":"crossref","first-page":"26\u2013","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity.","volume":"393:","author":"Aronne","year":"2025;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B104","doi-asserted-by":"crossref","first-page":"1193\u2013","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity.","volume":"391:","author":"Malhotra","year":"2024;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B105","doi-asserted-by":"crossref","first-page":"299\u2013","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis.","volume":"391:","author":"Loomba","year":"2024;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B106","doi-asserted-by":"crossref","first-page":"427\u2013","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity.","volume":"392:","author":"Packer","year":"2025;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B107","article-title":"Lilly's Mounjaro(tirzepatide), a GIP\/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease.","author":"Lilly Investors.","year":"(2025)."},{"key":"key20260311095033_B108","doi-asserted-by":"crossref","first-page":"447\u2013","DOI":"10.1016\/S2213-8587(24)00102-5","article-title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis.","volume":"12:","author":"Usman","year":"2024;","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key20260311095033_B109","doi-asserted-by":"crossref","first-page":"2013\u2013","DOI":"10.1097\/00004872-199816121-00024","article-title":"Treatment with orlistat reduces cardiovascular risk in obese patients.","volume":"16:","author":"Zavoral","year":"1998;","journal-title":"J Hypertens"},{"key":"key20260311095033_B110","doi-asserted-by":"crossref","first-page":"167\u2013","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.","volume":"352:","author":"Sj\u00f6str\u00f6m","year":"1998;","journal-title":"Lancet"},{"key":"key20260311095033_B111","doi-asserted-by":"crossref","first-page":"1173\u2013","DOI":"10.1007\/s00431-023-05369-3","article-title":"The effect of orlistat in the treatment of non-alcoholic fatty liver in adolescents with overweight and obese.","volume":"183:","author":"Zahmatkesh","year":"2024;","journal-title":"Eur J Pediatr"},{"key":"key20260311095033_B112","first-page":"8326\u2013","article-title":"Significance of orlistat in management of dyslipidemia, systolic blood pressure and body mass index.","volume":"26:","author":"Alanazi","year":"2022;","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20260311095033_B113","doi-asserted-by":"crossref","first-page":"105649.","DOI":"10.1016\/j.phrs.2021.105649","article-title":"Pharmacotherapy of obesity: an update.","volume":"169:","author":"Cignarella","year":"2021;","journal-title":"Pharmacol Res"},{"key":"key20260311095033_B114","doi-asserted-by":"crossref","first-page":"330\u2013","DOI":"10.1038\/oby.2011.330","article-title":"Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP).","volume":"20:","author":"Allison","year":"2012;","journal-title":"Obesity (Silver Spring)"},{"key":"key20260311095033_B115","doi-asserted-by":"crossref","first-page":"1\u2013","DOI":"10.1016\/j.phrs.2014.04.004","article-title":"Naltrexone\/bupropion for obesity: an investigational combination pharmacotherapy for weight loss.","volume":"84:","author":"Billes","year":"2014;","journal-title":"Pharmacol Res"},{"key":"key20260311095033_B116","first-page":"751\u2013","article-title":"Naltrexone HCI\/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives.","volume":"10:","author":"Tek","year":"2016;","journal-title":"Patient Prefer Adherence"},{"key":"key20260311095033_B117","doi-asserted-by":"crossref","first-page":"595\u2013","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"376:","author":"Greenway","year":"2010;","journal-title":"Lancet"},{"key":"key20260311095033_B118","doi-asserted-by":"crossref","first-page":"935\u2013","DOI":"10.1002\/oby.20309","article-title":"A randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II).","volume":"21:","author":"Apovian","year":"2013;","journal-title":"Obesity (Silver Spring)"},{"key":"key20260311095033_B119","doi-asserted-by":"crossref","first-page":"4022\u2013","DOI":"10.2337\/dc13-0234","article-title":"Effects of naltrexone sustained-release\/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes.","volume":"36:","author":"Hollander","year":"2013;","journal-title":"Diabetes Care"},{"key":"key20260311095033_B120","doi-asserted-by":"crossref","first-page":"110\u2013","DOI":"10.1038\/oby.2010.147","article-title":"Weight loss with naltrexone SR\/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.","volume":"19:","author":"Wadden","year":"2011;","journal-title":"Obesity (Silver Spring)"},{"key":"key20260311095033_B121","article-title":"Phentermine\/topiramate (Qsymia) for chronic weight management.","author":"Gazewood","year":"2024."},{"key":"key20260311095033_B122","doi-asserted-by":"crossref","first-page":"635\u2013","DOI":"10.1056\/NEJMoa2502081","article-title":"Coadministered cagrilintide and semaglutide in adults with overweight or obesity.","volume":"393:","author":"Garvey","year":"2025;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B123","doi-asserted-by":"crossref","first-page":"1065\u2013","DOI":"10.1056\/NEJMoa2505669","article-title":"Orforglipron, an oral small-molecule GLP-1 receptor agonist, in early type 2 diabetes.","volume":"393:","author":"Rosenstock","year":"2025;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B124","doi-asserted-by":"crossref","first-page":"12\u2013","DOI":"10.1038\/nrendo.2017.122","article-title":"Current pharmacotherapy for obesity.","volume":"14:","author":"Srivastava","year":"2018;","journal-title":"Nat Rev Endocrinol"},{"key":"key20260311095033_B125","doi-asserted-by":"crossref","first-page":"439\u2013","DOI":"10.1097\/00000658-195409000-00018","article-title":"An experimental evaluation of the nutritional importance of proximal and distal small intestine.","volume":"140:","author":"Kremen","year":"1954;","journal-title":"Ann Surg"},{"key":"key20260311095033_B126","doi-asserted-by":"crossref","first-page":"1786\u2013","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.","volume":"401:","author":"Verrastro","year":"2023;","journal-title":"Lancet"},{"key":"key20260311095033_B127","doi-asserted-by":"crossref","first-page":"1143\u2013","DOI":"10.1056\/NEJMoa1700459","article-title":"Weight and metabolic outcomes 12 years after gastric bypass.","volume":"377:","author":"Adams","year":"2017;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B128","doi-asserted-by":"crossref","first-page":"591\u2013","DOI":"10.1210\/jc.2004-2211","article-title":"Why do patients lose weight after Roux-en-Y gastric bypass?","volume":"90:","author":"Le Roux","year":"2005;","journal-title":"J Clin Endocrinol Metab"},{"key":"key20260311095033_B129","doi-asserted-by":"crossref","first-page":"410\u2013","DOI":"10.1007\/s11695-015-1945-7","article-title":"Mechanism underlying the weight loss and complications of Roux-en-Y gastric bypass.","volume":"26:","author":"Abdeen","year":"2016;","journal-title":"Review Obes Surg"},{"key":"key20260311095033_B130","doi-asserted-by":"crossref","first-page":"100836.","DOI":"10.1016\/j.lanepe.2024.100836","article-title":"Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase III multicentre randomised controlled trial (SleeveBypass).","volume":"38:","author":"Biter","year":"2024;","journal-title":"Lancet Reg Health Eur"},{"key":"key20260311095033_B131","doi-asserted-by":"crossref","first-page":"e2353141.","DOI":"10.1001\/jamanetworkopen.2023.53141","article-title":"Comparison of sleeve gastrectomy vs Roux-en-Y gastric bypass: a randomized clinical trial.","volume":"7:","author":"Hedberg","year":"2024;","journal-title":"JAMA Netw Open"},{"key":"key20260311095033_B132","doi-asserted-by":"crossref","first-page":"1965\u2013","DOI":"10.1016\/S0140-6736(21)02394-1","article-title":"Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial.","volume":"398:","author":"Abu Dayyeh","year":"2021;","journal-title":"Lancet"},{"key":"key20260311095033_B133","doi-asserted-by":"crossref","first-page":"405\u2013","DOI":"10.1016\/j.soard.2012.11.011","article-title":"Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial.","volume":"9:","author":"Angrisani","year":"2013;","journal-title":"Surg Obes Relat Dis"},{"key":"key20260311095033_B134","doi-asserted-by":"crossref","first-page":"936\u2013","DOI":"10.1007\/s002689900497","article-title":"Biliopancreatic diversion.","volume":"22:","author":"Scopinaro","year":"1998;","journal-title":"World J Surg"},{"key":"key20260311095033_B135","doi-asserted-by":"crossref","first-page":"202\u2013","DOI":"10.1016\/j.ciresp.2021.01.008","article-title":"Experience in biliopancreatic diversion with duodenal switch: results at 2, 5 and 10 years.","volume":"100:","author":"Sorribas","year":"2022;","journal-title":"Cir Esp (Engl Ed)"},{"key":"key20260311095033_B136","doi-asserted-by":"crossref","first-page":"1724\u2013","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery: a systematic review and meta-analysis.","volume":"292:","author":"Buchwald","year":"2004;","journal-title":"JAMA"},{"key":"key20260311095033_B137","doi-asserted-by":"crossref","first-page":"2417\u2013","DOI":"10.1001\/jama.2017.6803","article-title":"Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement.","volume":"317:","author":"Grossman","year":"2017;","journal-title":"JAMA"},{"key":"key20260311095033_B138","article-title":"Overweight and obesity management.","author":"National Institute for Health and Care Excellence.","year":"(2025)."},{"key":"key20260311095033_B139","doi-asserted-by":"crossref","first-page":"555\u2013","DOI":"10.1056\/NEJMoa2407379","article-title":"Liraglutide for children 6 to <12 years of age with obesity- a randomized trial.","volume":"392:","author":"Fox","year":"2025;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B140","doi-asserted-by":"crossref","first-page":"2245\u2013","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity.","volume":"387:","author":"Weghuber","year":"2022;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B141","doi-asserted-by":"crossref","first-page":"2117\u2013","DOI":"10.1056\/NEJMoa1916038","article-title":"A randomized, controlled trial of liraglutide for adolescents with obesity.","volume":"382:","author":"Kelly","year":"2020;","journal-title":"N Engl J Med"},{"key":"key20260311095033_B142","doi-asserted-by":"crossref","first-page":"e178\u2013","DOI":"10.1097\/AOG.0000000000003772","article-title":"Physical activity and exercise during pregnancy and the postpartum period: ACOG Committee Opinion Summary, Number 804.","volume":"135:","year":"2020;","journal-title":"Obstet Gynecol"},{"key":"key20260311095033_B143","doi-asserted-by":"crossref","first-page":"300\u2013","DOI":"10.1002\/ijgo.12804","article-title":"Autologous transobturator sling as an alternative therapy for stress urinary incontinence.","volume":"145:","author":"Laufer","year":"2019;","journal-title":"Int J Gynaecol Obstet"},{"key":"key20260311095033_B144","doi-asserted-by":"crossref","first-page":"e62\u2013","DOI":"10.1111\/1471-0528.15386","article-title":"Care of women with obesity in pregnancy: green-top guideline No. 72.","volume":"126:","author":"Denison","year":"2019;","journal-title":"BJOG"},{"key":"key20260311095033_B145","volume-title":"Weight gain during pregnancy: reexamining the guidelines.","author":"Institute of Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy Weight Guidelines.","year":"2009."},{"key":"key20260311095033_B146","unstructured":"National Institute for Health and Care Excellence. (2010). PH27: Weight management before, during, and after pregnancy. [online] Available from: https:\/\/www.nice.org.uk\/guidance\/ph27 [Last accessed on February, 2026] [Last accessed on February, 2026]"},{"key":"key20260311095033_B147","doi-asserted-by":"crossref","first-page":"1571\u2013","DOI":"10.1016\/j.jogc.2018.04.003","article-title":"Risk of thromboembolic disease with cost estimates in patients undergoing robotic-assisted surgery for endometrial cancer and review of the literature.","volume":"40:","author":"Laskov","year":"2018;","journal-title":"J Obstet Gynaecol Can"},{"key":"key20260311095033_B148","first-page":"S295\u2013","article-title":"American Diabetes Association Professional Practice Committee. Diabetes care in the hospital: standards of care in diabetes-2024.","volume":"47:","year":"2023;","journal-title":"Diabetes Care"},{"key":"key20260311095033_B149","doi-asserted-by":"crossref","first-page":"1\u2013","DOI":"10.4158\/EP.14.S1.1","article-title":"American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient.","volume":"14:","author":"Mechanick","year":"2008;","journal-title":"Endocr Pract"},{"key":"key20260311095033_B150","doi-asserted-by":"crossref","first-page":"e40589.","DOI":"10.2196\/40589","article-title":"Applications of artificial intelligence to obesity research: scoping review of methodologies.","volume":"24:","author":"An","year":"2022;","journal-title":"J Med Internet Res"},{"key":"key20260311095033_B151","doi-asserted-by":"crossref","first-page":"22424.","DOI":"10.1038\/s41598-024-73826-6","article-title":"Visualization obesity risk prediction system based on machine learning.","volume":"14:","author":"Du","year":"2024;","journal-title":"Sci Rep"},{"key":"key20260311095033_B152","doi-asserted-by":"crossref","first-page":"68.","DOI":"10.4081\/cardio.2025.68","article-title":"The Global Implementation Guidelines Initiative: how to optimize cardiorenal metabolic care worldwide.","volume":"3:","author":"Pinto","year":"2025;","journal-title":"Global Cardiology"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:50:57Z","timestamp":1773222657000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-74-3-e1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":152,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.59556\/japi.74.1445"],"URL":"https:\/\/doi.org\/10.59556\/japi.74.1445","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}